A Rapamycin Pharmacogenomic Approach for the Childhood Dementia N iemann‐ P ick C
Journal of Inherited Metabolic Disease · 2026-07 · 49 (4)
DOI: 10.1002/jimd.70214 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 18.06.2026. Verfasst von Benjamín Szenfeld und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Genética y Genómica, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, Chile. Hauptthemen laut MEDLINE: Sirolimus, Niemann-Pick Disease, Type C. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fondo Nacional de Desarrollo Científico y Tecnológico, FONDEQUIP EQM150093 ANID-CHILE.
Themen: Demenz
Abstract (Originalsprache)
Niemann‐Pick type C (NPC) is a childhood dementia characterized by lysosomal lipid accumulation. In Npc1 −/− mice, Rapamycin, an autophagy inductor, yielded opposite results depending on genetic background, suggesting the presence of pharmacogenomic modifiers. To identify them, we used a genotyped yeast panel designed for gene mapping and the NPC‐mimetic U18666A (U18‐drug) in the presence and absence of rapamycin. We evaluated cell growth, vacuolar fragmentation, and transcriptomics across diverse strains. Linkage analysis based on cell growth identified a significant locus, leading to the prioritization of nine genes. Notably, ccs1 (copper chaperone for superoxide dismutase) and avo2 (TORC2 subunit) deletions decreased cell growth compared to U18‐Rapa in WT cells, while irc21 (DNA damage and ceramide metabolism) increased it. Our results suggest that genomic variants within these genes should be assessed before using rapamycin for NPC. This study represents a crucial step towards personalized rapamycin therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Genética y Genómica, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, Chile.
- Centro de Genómica y Bioinformática, Facultad de Ciencias, Ingeniería y Tecnología, Universidad Mayor, Santiago, Chile.
- Millennium Institute for Integrative Biology (iBio), Santiago, Chile.
- Departamento de Biología, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago, Chile.
- Millenium Nucleus of Patagonian Limit of Life (LiLi), Valdivia, Chile.
ORCID-Profile: Pablo Villarreal, Francisco A Cubillos, Andrés D Klein
Förderung
- Fondo Nacional de Desarrollo Científico y Tecnológico
- FONDEQUIP EQM150093 ANID-CHILE
Zitieren
APA
Szenfeld, B., Las Heras, M., Rubilar, J. C., Villarreal, P., Olguín, V., Cubillos, F. A., & Klein, A. D. (2026). A Rapamycin Pharmacogenomic Approach for the Childhood Dementia N iemann‐ P ick C. Journal of Inherited Metabolic Disease, 49(4). https://doi.org/10.1002/jimd.70214
Vancouver
Szenfeld B, Las Heras M, Rubilar JC, Villarreal P, Olguín V, Cubillos FA, et al. A Rapamycin Pharmacogenomic Approach for the Childhood Dementia N iemann‐ P ick C. Journal of Inherited Metabolic Disease. 2026;49(4). doi:10.1002/jimd.70214
BibTeX
@article{Szenfeld2026,
author = {Szenfeld, Benjamín and Las Heras, Macarena and Rubilar, Juan Carlos and Villarreal, Pablo and Olguín, Valeria and Cubillos, Francisco A and Klein, Andrés D},
title = {A Rapamycin Pharmacogenomic Approach for the Childhood Dementia N iemann‐ P ick C},
journal = {Journal of Inherited Metabolic Disease},
year = {2026},
volume = {49},
number = {4},
doi = {10.1002/jimd.70214}
}
EUVIMED